| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 38.4445 | 3 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.8416 | 31 |
| GSM780709 | Untreated after 4 days (C3_1) | 36.9958 | 1 |
| GSM780719 | Untreated after 4 days (C1_2) | 38.8801 | 4 |
| GSM780720 | Untreated after 4 days (C2_2) | 40.9815 | 9 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.8901 | 22 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 35.7311 | 1 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 40.3761 | 7 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 37.7478 | 2 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 42.2997 | 14 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.8862 | 27 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 37.6405 | 2 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 39.212 | 5 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 41.2036 | 10 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.7451 | 16 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.8168 | 17 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.8567 | 21 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 35.0205 | 1 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.7463 | 21 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 41.3025 | 10 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.7373 | 21 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.0637 | 49 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 39.0588 | 4 |